|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0018787,
umls-concept:C0034897,
umls-concept:C0035015,
umls-concept:C0035647,
umls-concept:C0178539,
umls-concept:C0332281,
umls-concept:C0333348,
umls-concept:C0449258,
umls-concept:C0450127,
umls-concept:C0681842,
umls-concept:C1522318,
umls-concept:C1548437,
umls-concept:C1882923,
umls-concept:C2828008,
umls-concept:C2936350
|
|
pubmed:issue |
15
|
|
pubmed:dateCreated |
2009-4-10
|
|
pubmed:abstractText |
This study was designed to investigate tissue characterization of the coronary allograft atherosclerotic plaque with virtual histology intravascular ultrasound (VH-IVUS) imaging to assess the presence and predictors of vessel wall inflammation and its significance in cardiac allograft vasculopathy (CAV) progression.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1558-3597
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
14
|
|
pubmed:volume |
53
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1279-86
|
|
pubmed:meshHeading |
pubmed-meshheading:19358941-Adult,
pubmed-meshheading:19358941-Aged,
pubmed-meshheading:19358941-Cohort Studies,
pubmed-meshheading:19358941-Coronary Artery Disease,
pubmed-meshheading:19358941-Disease Progression,
pubmed-meshheading:19358941-Female,
pubmed-meshheading:19358941-Graft Rejection,
pubmed-meshheading:19358941-Heart Transplantation,
pubmed-meshheading:19358941-Humans,
pubmed-meshheading:19358941-Inflammation,
pubmed-meshheading:19358941-Male,
pubmed-meshheading:19358941-Middle Aged,
pubmed-meshheading:19358941-Recurrence,
pubmed-meshheading:19358941-Retrospective Studies,
pubmed-meshheading:19358941-Risk Factors,
pubmed-meshheading:19358941-Ultrasonography, Interventional
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Inflammatory burden of cardiac allograft coronary atherosclerotic plaque is associated with early recurrent cellular rejection and predicts a higher risk of vasculopathy progression.
|
|
pubmed:affiliation |
Mayo Clinic, Rochester, Minnesota 55905, USA.
|
|
pubmed:publicationType |
Journal Article
|
